{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:10:44Z","timestamp":1790802644094,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ping Tung Christian Hospital","award":["PS112009"],"award-info":[{"award-number":["PS112009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05008-7","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:17:28Z","timestamp":1778566648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct longitudinal trajectories of alkaline phosphatase and parathyroid hormone at dialysis initiation predict mortality in incident hemodialysis patients"],"prefix":"10.1186","volume":"27","author":[{"given":"Chin-Wen","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ching","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hsun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih\u2011Feng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Hsiang","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"4","key":"5008_CR1","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL, McArthur E, Leslie WD, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86(4):810\u20138.","journal-title":"Kidney Int"},{"issue":"1","key":"5008_CR2","first-page":"1","volume":"7","author":"Kidney Disease: Improving Global Outcomes","year":"2017","unstructured":"CKDMBDUWG, Kidney Disease: Improving Global Outcomes. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1\u201359.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"4","key":"5008_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ekir.2024.01.002","volume":"9","author":"S Yamamoto","year":"2024","unstructured":"Yamamoto S, Jorgensen HS, Zhao J, et al. Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS. Kidney Int Rep. 2024;9(4):863\u201376.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"5008_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70(4):771\u201380.","journal-title":"Kidney Int"},{"issue":"11","key":"5008_CR5","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2008010014","volume":"19","author":"DL Regidor","year":"2008","unstructured":"Regidor DL, Kovesdy CP, Mehrotra R, et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008;19(11):2193\u2013203.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"5008_CR6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2215\/CJN.09471209","volume":"5","author":"C Gardham","year":"2010","unstructured":"Gardham C, Stevens PE, Delaney MP, LeRoux M, Coleman A, Lamb EJ. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol. 2010;5(7):1261\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5008_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ki.2012.77","volume":"82","author":"S Sardiwal","year":"2012","unstructured":"Sardiwal S, Gardham C, Coleman AE, Stevens PE, Delaney MP, Lamb EJ. Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney Int. 2012;82(1):100\u20135.","journal-title":"Kidney Int"},{"issue":"1","key":"5008_CR8","doi-asserted-by":"publisher","first-page":"2449572","DOI":"10.1080\/0886022X.2024.2449572","volume":"47","author":"CH Chang","year":"2025","unstructured":"Chang CH, Liou HH, Wu CK. Moderate-severe aortic arch calcification and high serum alkaline phosphatase co-modify the risk of cardiovascular events and mortality among chronic hemodialysis patients. Ren Fail. 2025;47(1):2449572.","journal-title":"Ren Fail"},{"issue":"5","key":"5008_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1053\/j.jrn.2019.10.004","volume":"30","author":"I Beberashvili","year":"2020","unstructured":"Beberashvili I, Samogalska O, Azar A, Stav K, Efrati S. Nutritional Status and Mortality Predictability for Time-Varying Serum Alkaline Phosphatase in Hemodialysis Patients: A Longitudinal Study. J Ren Nutr. 2020;30(5):452\u201361.","journal-title":"J Ren Nutr"},{"key":"5008_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bone.2014.01.016","volume":"61","author":"E Streja","year":"2014","unstructured":"Streja E, Wang HY, Lau WL, et al. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone. 2014;61:201\u20137.","journal-title":"Bone"},{"issue":"2","key":"5008_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000444890","volume":"43","author":"M Soohoo","year":"2016","unstructured":"Soohoo M, Feng M, Obi Y, et al. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016;43(2):85\u201396.","journal-title":"Am J Nephrol"},{"key":"5008_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"key":"5008_CR13","doi-asserted-by":"publisher","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","volume":"40","author":"LY Lin","year":"2018","unstructured":"Lin LY, Warren-Gash C, Smeeth L, Chen PC. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2018;40:e2018062.","journal-title":"Epidemiol Health"},{"issue":"4","key":"5008_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0049124106292364","volume":"35","author":"BL Jones","year":"2007","unstructured":"Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol methods Res. 2007;35(4):542\u201371.","journal-title":"Sociol methods Res"},{"issue":"2","key":"5008_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/ndt\/gfw412","volume":"33","author":"K Sumida","year":"2018","unstructured":"Sumida K, Molnar MZ, Potukuchi PK, et al. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transpl. 2018;33(2):264\u201373.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"5008_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ekir.2022.02.022","volume":"7","author":"A El-Husseini","year":"2022","unstructured":"El-Husseini A, Abdalbary M, Lima F, et al. Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD. Kidney Int Rep. 2022;7(5):1016\u201326.","journal-title":"Kidney Int Rep"},{"issue":"4 Suppl 4","key":"5008_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","volume":"53","author":"R Bhuriya","year":"2009","unstructured":"Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2009;53(4 Suppl 4):S3\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"5008_CR18","doi-asserted-by":"publisher","first-page":"e0202417","DOI":"10.1371\/journal.pone.0202417","volume":"13","author":"S Borrelli","year":"2018","unstructured":"Borrelli S, Chiodini P, De Nicola L, et al. Prognosis and determinants of serum PTH changes over time in 1\u20135 CKD stage patients followed in tertiary care. PLoS ONE. 2018;13(8):e0202417.","journal-title":"PLoS ONE"},{"issue":"1","key":"5008_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12882-018-1056-5","volume":"19","author":"S Yamamoto","year":"2018","unstructured":"Yamamoto S, Karaboyas A, Komaba H, et al. Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS). BMC Nephrol. 2018;19(1):253.","journal-title":"BMC Nephrol"},{"issue":"3","key":"5008_CR20","doi-asserted-by":"publisher","first-page":"sfag022","DOI":"10.1093\/ckj\/sfag022","volume":"19","author":"Y Kim","year":"2026","unstructured":"Kim Y, Wu PH, Kwon S, et al. Intra-individual fluctuations in alkaline phosphatase predict mortality and CKD progression: insights from a large CKD cohort. Clin Kidney J. 2026;19(3):sfag022.","journal-title":"Clin Kidney J"},{"issue":"6","key":"5008_CR21","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/ndt\/gfs598","volume":"28","author":"J Li","year":"2013","unstructured":"Li J, Molnar MZ, Zaritsky JJ, et al. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transpl. 2013;28(6):1516\u201325.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"5008_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","volume":"62","author":"S Sardiwal","year":"2013","unstructured":"Sardiwal S, Magnusson P, Goldsmith DJ, Lamb EJ. Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis. 2013;62(4):810\u201322.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"5008_CR23","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.2215\/CJN.10091110","volume":"6","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Verduijn M, Pilz S, et al. Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol. 2011;6(7):1752\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5008_CR24","doi-asserted-by":"publisher","first-page":"13224","DOI":"10.1038\/s41598-017-13387-z","volume":"7","author":"Y Fan","year":"2017","unstructured":"Fan Y, Jin X, Jiang M, Fang N. Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis. Sci Rep. 2017;7(1):13224.","journal-title":"Sci Rep"},{"issue":"4","key":"5008_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1053\/j.ajkd.2013.04.012","volume":"62","author":"JJ Taliercio","year":"2013","unstructured":"Taliercio JJ, Schold JD, Simon JF, et al. Prognostic importance of serum alkaline phosphatase in CKD stages 3\u20134 in a clinical population. Am J Kidney Dis. 2013;62(4):703\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"5008_CR26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.numecd.2020.04.029","volume":"30","author":"DW Kim","year":"2020","unstructured":"Kim DW, Hwang SY, Nam YJ, Kim D, Shin SJ, Yoon HE. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease. Nutr Metab Cardiovasc Dis. 2020;30(9):1476\u201383.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"5008_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ndt\/gfab184","volume":"37","author":"M Bozic","year":"2022","unstructured":"Bozic M, Diaz-Tocados JM, Bermudez-Lopez M, et al. Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort. Nephrol Dial Transpl. 2022;37(4):663\u201372.","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"5008_CR28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/ki.2008.64","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008;73(11):1296\u2013302.","journal-title":"Kidney Int"},{"issue":"1","key":"5008_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10(1):98\u2013109.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"5008_CR30","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s00198-016-3636-1","volume":"27","author":"SA Lee","year":"2016","unstructured":"Lee SA, Lee MJ, Ryu GW, et al. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporos Int. 2016;27(9):2717\u201326.","journal-title":"Osteoporos Int"},{"issue":"7","key":"5008_CR31","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2215\/CJN.11931116","volume":"12","author":"M Wang","year":"2017","unstructured":"Wang M, Obi Y, Streja E, et al. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017;12(7):1118\u201327.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"5008_CR32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1053\/ajkd.2001.29254","volume":"38","author":"MM Avram","year":"2001","unstructured":"Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis. 2001;38(6):1351\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"5008_CR33","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fernandez-Martin","year":"2015","unstructured":"Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transpl. 2015;30(9):1542\u201351.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5008_CR34","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","volume":"26","author":"M Naves-Diaz","year":"2011","unstructured":"Naves-Diaz M, Passlick-Deetjen J, Guinsburg A, et al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transpl. 2011;26(6):1938\u201347.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"5008_CR35","doi-asserted-by":"publisher","first-page":"e0173831","DOI":"10.1371\/journal.pone.0173831","volume":"12","author":"R Villa-Bellosta","year":"2017","unstructured":"Villa-Bellosta R, Rodriguez-Osorio L, Mas S, et al. A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients. PLoS ONE. 2017;12(3):e0173831.","journal-title":"PLoS ONE"},{"issue":"3","key":"5008_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ndt\/gfz060","volume":"35","author":"C Lamina","year":"2020","unstructured":"Lamina C, Kronenberg F, Stenvinkel P, et al. Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort. Nephrol Dial Transpl. 2020;35(3):478\u201387.","journal-title":"Nephrol Dial Transpl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05008-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:18:44Z","timestamp":1783394324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05008-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05008-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Ping Tung Christian Hospital (IRB No. 724\u00a0A) and conducted in accordance with the Declaration of Helsinki. The requirement for informed consent was waived due to the retrospective design and use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}